Can Trimetazidine Tablets replace the sustained-release tablets?

Whether trimetazidine tablets can be replaced by sustained-release tablets depends on the specific circumstances. Trimetazidine tablets and sustained-release tablets have similar therapeutic effects; both can be used in the treatment of cardiovascular diseases, such as angina pectoris.

Trimetazidine tablets are primarily used to improve myocardial blood supply. By protecting cellular energy metabolism under conditions of ischemia or hypoxia and maintaining intracellular homeostasis, they help treat coronary heart disease and angina pectoris. Sustained-release tablets, on the other hand, offer multiple therapeutic benefits, including analgesia, blood pressure reduction, and anti-anginal effects. These tablets slowly release their active ingredients, allowing for prolonged drug action and potentially reducing adverse drug effects.

Trimetazidine tablets cannot simply substitute sustained-release tablets. The choice between the two should be based on the patient's specific condition and the judgment of a physician. For example, during an acute episode or when rapid onset of action is required, regular tablets may be preferred. However, when long-term symptom control and reduction of drug side effects are needed, sustained-release tablets may be more appropriate.

Patients should strictly follow medical advice when selecting medications, choosing the most suitable drug based on their individual condition and physical status.